Adrenomedullin-mediated relaxations in veins are endothelium-dependent and distinct from arteries

D. A. Barber, Y. S. Park, John C Jr. Burnett, Virginia M Miller

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In arteries, adrenomedullin (ADM) causes relaxations of rings with and without endothelium by stimulating accumulation of cyclic nucleotides resulting from activation of the ADM and calcitonin gene-related peptide (CGRP) receptors. Experiments were designed to determine the mechanism(s) of relaxation to ADM in veins. Rings of canine femoral vein with and without endothelium were suspended in organ chambers for measurement of isometric force. Rings were contracted with prostaglandin F(2α) (2 x 10 -6 M), and cumulative dose-responses to ADM (10 -11 10 -7 M) were obtained in the absence or presence of indomethacin (10 -5 M), indomethacin + N(G)-mono- methyl-L-arginine (10 -4 M), methylene blue (10 -5 M), particulate guanylate cyclase inhibitor HS-142-1 (10 -5 M), tetraethylammonium (TEA, 10 -2 M), CGRP-receptor antagonist (CGRP 8-37, 10 -6 M), ADM-receptor antagonist (ADM 26-52, 10 -6 M), diphenhydramine (10 -6 M), 8- phenyltheophylline (3 x 10 -6 M), or superoxide dismutase (150 U/ml) plus catalase (1,200 U/ml). ADM produced concentration-dependent relaxations only in veins with endothelium. Relaxations to ADM in rings with endothelium were significantly inhibited only by methylene blue and HS-142-1. In separate experiments, incubation of rings with ADM (10 -8 M) and 3-isobutyl-1- methyl-xanthine (10 -4 M) for 3 min did not significantly affect the accumulation of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP). These data suggest that ADM-mediated relaxation in veins is endothelium dependent and is not associated with activation of CGRP receptors or currently defined ADM receptors. Further, relaxations are not mediated by nitric oxide, indomethacin-sensitive prostanoids. TEA-sensitive hyperpolarizing factors, oxygen free radicals, or accumulation of cyclic nucleotides.

Original languageEnglish (US)
Pages (from-to)695-701
Number of pages7
JournalJournal of Cardiovascular Pharmacology
Volume30
Issue number5
DOIs
StatePublished - 1997

Fingerprint

Adrenomedullin
Endothelium
Veins
Arteries
Calcitonin Gene-Related Peptide Receptors
Adrenomedullin Receptors
Indomethacin
Methylene Blue
Cyclic Nucleotides
Diphenhydramine
Tetraethylammonium
Xanthine
Femoral Vein
Guanylate Cyclase
Prostaglandins F
Catalase
Superoxide Dismutase
Free Radicals
Prostaglandins
Arginine

Keywords

  • CGRP
  • Cyclooxygenase
  • Guanylate cyclase

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Adrenomedullin-mediated relaxations in veins are endothelium-dependent and distinct from arteries. / Barber, D. A.; Park, Y. S.; Burnett, John C Jr.; Miller, Virginia M.

In: Journal of Cardiovascular Pharmacology, Vol. 30, No. 5, 1997, p. 695-701.

Research output: Contribution to journalArticle

@article{04cfe2cad5bf4c41bdb99195f8f7b909,
title = "Adrenomedullin-mediated relaxations in veins are endothelium-dependent and distinct from arteries",
abstract = "In arteries, adrenomedullin (ADM) causes relaxations of rings with and without endothelium by stimulating accumulation of cyclic nucleotides resulting from activation of the ADM and calcitonin gene-related peptide (CGRP) receptors. Experiments were designed to determine the mechanism(s) of relaxation to ADM in veins. Rings of canine femoral vein with and without endothelium were suspended in organ chambers for measurement of isometric force. Rings were contracted with prostaglandin F(2α) (2 x 10 -6 M), and cumulative dose-responses to ADM (10 -11 10 -7 M) were obtained in the absence or presence of indomethacin (10 -5 M), indomethacin + N(G)-mono- methyl-L-arginine (10 -4 M), methylene blue (10 -5 M), particulate guanylate cyclase inhibitor HS-142-1 (10 -5 M), tetraethylammonium (TEA, 10 -2 M), CGRP-receptor antagonist (CGRP 8-37, 10 -6 M), ADM-receptor antagonist (ADM 26-52, 10 -6 M), diphenhydramine (10 -6 M), 8- phenyltheophylline (3 x 10 -6 M), or superoxide dismutase (150 U/ml) plus catalase (1,200 U/ml). ADM produced concentration-dependent relaxations only in veins with endothelium. Relaxations to ADM in rings with endothelium were significantly inhibited only by methylene blue and HS-142-1. In separate experiments, incubation of rings with ADM (10 -8 M) and 3-isobutyl-1- methyl-xanthine (10 -4 M) for 3 min did not significantly affect the accumulation of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP). These data suggest that ADM-mediated relaxation in veins is endothelium dependent and is not associated with activation of CGRP receptors or currently defined ADM receptors. Further, relaxations are not mediated by nitric oxide, indomethacin-sensitive prostanoids. TEA-sensitive hyperpolarizing factors, oxygen free radicals, or accumulation of cyclic nucleotides.",
keywords = "CGRP, Cyclooxygenase, Guanylate cyclase",
author = "Barber, {D. A.} and Park, {Y. S.} and Burnett, {John C Jr.} and Miller, {Virginia M}",
year = "1997",
doi = "10.1097/00005344-199711000-00022",
language = "English (US)",
volume = "30",
pages = "695--701",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Adrenomedullin-mediated relaxations in veins are endothelium-dependent and distinct from arteries

AU - Barber, D. A.

AU - Park, Y. S.

AU - Burnett, John C Jr.

AU - Miller, Virginia M

PY - 1997

Y1 - 1997

N2 - In arteries, adrenomedullin (ADM) causes relaxations of rings with and without endothelium by stimulating accumulation of cyclic nucleotides resulting from activation of the ADM and calcitonin gene-related peptide (CGRP) receptors. Experiments were designed to determine the mechanism(s) of relaxation to ADM in veins. Rings of canine femoral vein with and without endothelium were suspended in organ chambers for measurement of isometric force. Rings were contracted with prostaglandin F(2α) (2 x 10 -6 M), and cumulative dose-responses to ADM (10 -11 10 -7 M) were obtained in the absence or presence of indomethacin (10 -5 M), indomethacin + N(G)-mono- methyl-L-arginine (10 -4 M), methylene blue (10 -5 M), particulate guanylate cyclase inhibitor HS-142-1 (10 -5 M), tetraethylammonium (TEA, 10 -2 M), CGRP-receptor antagonist (CGRP 8-37, 10 -6 M), ADM-receptor antagonist (ADM 26-52, 10 -6 M), diphenhydramine (10 -6 M), 8- phenyltheophylline (3 x 10 -6 M), or superoxide dismutase (150 U/ml) plus catalase (1,200 U/ml). ADM produced concentration-dependent relaxations only in veins with endothelium. Relaxations to ADM in rings with endothelium were significantly inhibited only by methylene blue and HS-142-1. In separate experiments, incubation of rings with ADM (10 -8 M) and 3-isobutyl-1- methyl-xanthine (10 -4 M) for 3 min did not significantly affect the accumulation of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP). These data suggest that ADM-mediated relaxation in veins is endothelium dependent and is not associated with activation of CGRP receptors or currently defined ADM receptors. Further, relaxations are not mediated by nitric oxide, indomethacin-sensitive prostanoids. TEA-sensitive hyperpolarizing factors, oxygen free radicals, or accumulation of cyclic nucleotides.

AB - In arteries, adrenomedullin (ADM) causes relaxations of rings with and without endothelium by stimulating accumulation of cyclic nucleotides resulting from activation of the ADM and calcitonin gene-related peptide (CGRP) receptors. Experiments were designed to determine the mechanism(s) of relaxation to ADM in veins. Rings of canine femoral vein with and without endothelium were suspended in organ chambers for measurement of isometric force. Rings were contracted with prostaglandin F(2α) (2 x 10 -6 M), and cumulative dose-responses to ADM (10 -11 10 -7 M) were obtained in the absence or presence of indomethacin (10 -5 M), indomethacin + N(G)-mono- methyl-L-arginine (10 -4 M), methylene blue (10 -5 M), particulate guanylate cyclase inhibitor HS-142-1 (10 -5 M), tetraethylammonium (TEA, 10 -2 M), CGRP-receptor antagonist (CGRP 8-37, 10 -6 M), ADM-receptor antagonist (ADM 26-52, 10 -6 M), diphenhydramine (10 -6 M), 8- phenyltheophylline (3 x 10 -6 M), or superoxide dismutase (150 U/ml) plus catalase (1,200 U/ml). ADM produced concentration-dependent relaxations only in veins with endothelium. Relaxations to ADM in rings with endothelium were significantly inhibited only by methylene blue and HS-142-1. In separate experiments, incubation of rings with ADM (10 -8 M) and 3-isobutyl-1- methyl-xanthine (10 -4 M) for 3 min did not significantly affect the accumulation of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP). These data suggest that ADM-mediated relaxation in veins is endothelium dependent and is not associated with activation of CGRP receptors or currently defined ADM receptors. Further, relaxations are not mediated by nitric oxide, indomethacin-sensitive prostanoids. TEA-sensitive hyperpolarizing factors, oxygen free radicals, or accumulation of cyclic nucleotides.

KW - CGRP

KW - Cyclooxygenase

KW - Guanylate cyclase

UR - http://www.scopus.com/inward/record.url?scp=0030777623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030777623&partnerID=8YFLogxK

U2 - 10.1097/00005344-199711000-00022

DO - 10.1097/00005344-199711000-00022

M3 - Article

C2 - 9388054

AN - SCOPUS:0030777623

VL - 30

SP - 695

EP - 701

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 5

ER -